Clinical trial
Rapamycin With Grapefruit Juice for Advanced Malignancies
NCT00375245 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00375245 |
|---|---|
| Title | Rapamycin With Grapefruit Juice for Advanced Malignancies |
| Official title | A Phase Ib Study Administering Rapamycin (Sirolimus) With Grapefruit Juice in Patients With Advanced Malignancies |
| Lead sponsor | University of Chicago, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors, Neoplasm Metastasis |
| Intervention type | Drug, Other |
| Interventions | Rapamycin (sirolimus), Grapefruit Juice |
| Enrollment | 41 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2012 |
| First posted | Sep 12, 2006 |
| Last update posted | Jan 17, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: